Pfizer/BioNTech COVID-19 vaccine highly protective in 12-18 age group - CDC
The new CDC study was conducted between June and September, when the extremely contagious Delta variant of the coronavirus was predominant.
A boy receives a dose of the Pfizer-BioNTech vaccine at Jerusalem’s Misgav Ladach Hospital on June 6, as Israel began its coronavirus vaccination campaign for 12-to-15 year olds(photo credit: MARC ISRAEL SELLEM)ByREUTERS
